Detalhe da pesquisa
1.
Altered HLA-A2-restricted TP53 epitope induces specific CTL cytotoxicity against hepatocellular carcinoma.
Eur J Immunol
; 53(5): e2250054, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36794567
2.
BCL2A1 neoepitopes-elicited cytotoxic T lymphocytes are a promising individualized immunotherapy of pancreatic cancer.
J Leukoc Biol
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38626292
3.
Interleukin-15 and chemokine ligand 19 enhance cytotoxic effects of chimeric antigen receptor T cells using zebrafish xenograft model of gastric cancer.
Front Immunol
; 13: 1002361, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36618357
4.
Altered MUC1 epitope-specific CTLs: A potential target for immunotherapy of pancreatic cancer.
J Leukoc Biol
; 112(6): 1577-1590, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36222123
5.
Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers.
Cancer Biol Med
; 18(4)2021 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35959968